BP
IDXX icon

Ballentine Partners’s Idexx Laboratories IDXX Stock Holding History

Ballentine Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$717K Buy
1,362
+103
+8% +$57.8K 0.01% 449
2026
Q1 		$707K Sell
1,259
-4
-0.3% -$2.56K 0.01% 428
2025
Q4 		$854K Buy
1,263
+76
+6% +$51.8K 0.01% 364
2025
Q3 		$758K Buy
1,187
+50
+4% +$30.3K 0.01% 385
2025
Q2 		$610K Sell
1,137
-341
-23% -$163K 0.01% 428
2025
Q1 		$621K Buy
1,478
+253
+21% +$110K 0.01% 383
2024
Q4 		$506K Sell
1,225
-19
-2% -$8.33K 0.01% 420
2024
Q3 		$628K Sell
1,244
-38
-3% -$18.5K 0.01% 371
2024
Q2 		$625K Buy
1,282
+94
+8% +$47.2K 0.01% 359
2024
Q1 		$641K Buy
1,188
+22
+2% +$12K 0.01% 340
2023
Q4 		$647K Buy
1,166
+622
+114% +$292K 0.01% 313
2023
Q3 		$238K Buy
544
+5
+0.9% +$2.49K 0.01% 500
2023
Q2 		$271K Buy
539
+13
+2% +$6.23K 0.01% 468
2023
Q1 		$263K Sell
526
-685
-57% -$328K 0.01% 451
2022
Q4 		$494K Buy
+1,211
New +$470K 0.01% 283
2022
Q1 		– Sell
-534
Closed -$351K – 492
2021
Q4 		$351K Buy
+534
New +$335K 0.01% 338
2020
Q4 		– Sell
-775
Closed -$304K – 397
2020
Q3 		$304K Buy
775
+2
+0.3% +$739 0.01% 292
2020
Q2 		$255K Buy
+773
New +$224K 0.01% 307
2019
Q4 		– Sell
-770
Closed -$210K – 412
2019
Q3 		$210K Sell
770
-6
-0.8% -$1.67K 0.01% 365
2019
Q2 		$214K Buy
+776
New +$191K 0.01% 353

Other funds holding IDXX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
MIM
Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ballentine Partners's IDXX Position: Q2 2026 in Review

Ballentine Partners increased its Idexx Laboratories (IDXX) stake by 8.2% in Q2 2026, buying an estimated $57.8K and bringing the position to 1,362 shares worth $717K. The position accounts for 0.01% of the portfolio, ranked #449.

Ballentine Partners first reported a position in IDXX in Q2 2019 and has held it in 20 quarters since. The position peaked at $854K in Q4 2025. 173 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ballentine Partners held 1,362 shares of Idexx Laboratories worth $717K as of Q2 2026.
  • Ballentine Partners bought 103 Idexx Laboratories shares in Q2 2026, an estimated $57.8K.
  • Idexx Laboratories made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #449 holding.
  • Ballentine Partners first reported a position in Idexx Laboratories in Q2 2019 and has held it in 20 quarters since.
  • Ballentine Partners's Idexx Laboratories position peaked at $854K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.